FIELD: medicine.
SUBSTANCE: method involves applying spectacle lenses. Fresnel prism of permanent action is set on the internal side of the spectacle lens before the healthy eye. The spectacles are advised for carrying every day at least for 2 h. The total treatment course is 7-10 days long. The total treatment course is 9-12 months long. Prism force is reduced depending on disease dynamics to residual secondary squint angle compensation. Prism direction, width and shape are diminished and moved to the spectacle lens zone corresponding to sight direction where uncompensated diplopia takes place.
EFFECT: enhanced effectiveness in restoring paralyzed muscles and eliminating squint and diplopia.
3 cl, 2 dwg, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ELIMINATING DIPLOPIA IN PARESIS OF THE EYE | 2021 |
|
RU2753957C1 |
METHOD FOR SELECTION OF PRISMATIC SPECTACLES FOR CHILDREN OF PREVERBAL AGE WITH CONCOMITANT SQUINT | 2020 |
|
RU2746651C1 |
METHOD FOR ELIMINATING EXOPHORIA COMPLICATED BY A-SYNDROME | 2020 |
|
RU2757260C1 |
FRESNEL PRISM | 1995 |
|
RU2093875C1 |
METHOD FOR TREATING PARALYTIC SQUINT CASES | 2006 |
|
RU2313318C1 |
METHOD FOR DETERMINING PARAMETERS OF HORIZONTAL-VERTICAL DIPLOPIA | 2020 |
|
RU2738861C1 |
METHOD FOR DETERMINING INDICATIONS FOR SURGERY OF NYSTAGMUS ASSOCIATED WITH STRABISMUS | 2022 |
|
RU2791653C1 |
METHOD FOR TREATMENT OF NYSTAGMUS IN ESOTROPIA | 2020 |
|
RU2757261C1 |
METHOD FOR DIAGNOSING STRABISMUS BY VIDEO EYE TRACKING | 2021 |
|
RU2767704C1 |
DEVICE FOR TREATING THE CASES OF RESTRICTIVE SQUINT ASSOCIATED WITH ENDOCRINE OPHTHALMOPATHY | 2006 |
|
RU2313319C1 |
Authors
Dates
2006-10-20—Published
2004-12-24—Filed